Eagle Pharmaceuticals: Q2 Earnings Insights

Eagle Pharmaceuticals EGRX reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:50 AM.

Here's what investors need to know about the announcement.

Eagle Pharmaceuticals posted an EPS of $1.56.

Revenue was up $26.01 million from the same period last year.

Last quarter the company beat on EPS by $0.16 which was followed by a 3.91% increase in the share price the next day.

Here's a look at Eagle Pharmaceuticals's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	3.88	0.94	0.83	0.80
EPS Actual	4.04	0.85	0.56	0.93
Revenue Estimate	123.33M	51.08M	46.40M	45.86M
Revenue Actual	115.87M	42.32M	39.85M	48.12M

To track all earnings releases for Eagle Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar